AMN Healthcare Services, Inc.

AMN Healthcare Services, Inc. (AMN) Market Cap

AMN Healthcare Services, Inc. has a market capitalization of $808.3M.

Financials based on reported quarter end 2025-12-31

Price: $20.91

0.08 (0.38%)

Market Cap: 808.30M

NYSE · time unavailable

CEO: Caroline Sullivan Grace

Sector: Healthcare

Industry: Medical - Care Facilities

IPO Date: 2001-11-13

Website: https://www.amnhealthcare.com

AMN Healthcare Services, Inc. (AMN) - Company Information

Market Cap: 808.30M · Sector: Healthcare

AMN Healthcare Services, Inc. provides healthcare workforce solutions and staffing services to hospitals and healthcare facilities in the United States. It operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. The Nurse and Allied Solutions segment offers travel nurse staffing, rapid response nurse staffing and labor disruption, allied staffing, local staffing, and revenue cycle solutions. The Physician and Leadership Solutions segment provides locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement solutions. The Technology and Workforce Solutions segment offers language services, vendor management systems, workforce optimization, telehealth, credentialing, and outsourced solutions. The company also provides allied health professionals, such as physical therapists, respiratory therapists, occupational therapists, medical and radiology technologists, lab technicians, speech pathologists, rehabilitation assistants, and pharmacists. It offers its services under the brands, including American Mobile, Nursefinders, NurseChoice, HealthSource Global Staffing, Onward Healthcare, O'Grady Peyton International, Med Travelers, Club Staffing, Staff Care, B.E. Smith, and Merritt Hawkins, as well as AMN Revenue Cycle Solutions and AMN Language Services. The company was founded in 1985 and is based in Dallas, Texas.

Analyst Sentiment

68%
Buy

Based on 17 ratings

Analyst 1Y Forecast: $22.70

Average target (based on 3 sources)

Consensus Price Target

Low

$20

Median

$23

High

$25

Average

$23

Potential Upside: 7.6%

Price & Moving Averages

Loading chart...

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 AMN HEALTHCARE INC (AMN) — Investment Overview

🧩 Business Model Overview

AMN Healthcare Inc (AMN) is a leading workforce solutions and healthcare staffing company, serving healthcare facilities across the United States. The company provides a comprehensive array of talent management services, including temporary and permanent placement of nurses, allied health professionals, physicians, and leadership personnel. AMN operates as a critical intermediary between healthcare organizations—from hospitals and outpatient centers to clinics and long-term care facilities—and a vast network of qualified healthcare professionals. The company’s platform-driven approach leverages technology and analytics to optimize the recruitment, placement, and management of human capital in a sector that is highly regulated and perpetually in need of skilled labor. By addressing staffing shortages and helping healthcare providers operate efficiently, AMN plays a vital, mission-critical role in the broader healthcare ecosystem.

💰 Revenue Streams & Monetisation Model

AMN Healthcare generates revenue through a diversified business model that encompasses several distinct but related segments:
  • Nurse and Allied Staffing: The largest revenue contributor, this segment supplies travel nurses, per diem nurses, and allied health professionals (such as therapists and technicians) to healthcare facilities on temporary assignments. AMN bills its clients (healthcare organizations) for these services, typically on a margin-over-payroll cost model.
  • Physician Staffing (Locum Tenens): AMN places physicians, advanced practice clinicians, and dentists on temporary contracts, targeting high-need specialties and locations. This business operates on a similar markup structure.
  • Permanent Placement and Recruitment Process Outsourcing (RPO): The company assists clients in recruiting and hiring full-time nurses, physicians, and executives, earning fees based on successful placements or ongoing management of the recruitment process.
  • Technology and Workforce Solutions: This growing segment includes vendor management systems (VMS), workforce optimization platforms, scheduling software, telehealth staffing, and consulting services. Clients pay subscription or service fees, often under multi-year contracts.
The contractual structures vary, ranging from contingency and retained search agreements to long-term workforce solutions engagements, providing AMN with both recurring and project-based revenue streams.

🧠 Competitive Advantages & Market Positioning

AMN maintains a leading market share in the highly fragmented healthcare staffing industry. Several core competitive advantages underpin its strong positioning:
  • Scale and Breadth of Services: AMN offers a one-stop solution for healthcare workforce needs, covering nursing, allied, physician, and leadership staffing. This enables deep client relationships and cross-selling opportunities.
  • National Talent Network: The company’s extensive database of credentialed healthcare professionals allows for rapid, high-quality placements, even in tight labor markets or specialized fields.
  • Technology Integration: The investment in proprietary platforms for workforce management, credentialing, and compliance streamlines the hiring process and strengthens client retention.
  • Brand Recognition and Client Loyalty: As one of the best-known providers, AMN enjoys long-standing partnerships with major health systems, providing both revenue stability and high switching costs for clients.
  • Regulatory and Credentialing Expertise: Navigating the complex regulatory environment in healthcare staffing requires knowledge and infrastructure, presenting a barrier to entry for smaller players.

🚀 Multi-Year Growth Drivers

The investment case for AMN is underpinned by several secular and company-specific growth drivers:
  • Demographic Trends: The aging U.S. population is driving increased demand for healthcare services. This, in turn, compounds staffing needs across all major provider types.
  • Ongoing Nurse and Physician Shortages: Structural shortages of healthcare professionals—exacerbated by burnout, retirements, and evolving care delivery models—create persistent demand for staffing and placement solutions.
  • Hospital Outsourcing: Healthcare facilities are increasingly relying on third-party staffing partners to manage fluctuating labor needs, preferring flexible and scalable solutions over building internal recruitment capacity.
  • Expansion of Technology-Driven Solutions: The adoption of VMS, scheduling tools, and telehealth staffing expands the addressable market and enables deeper client integration.
  • M&A and Service Line Extension: AMN's disciplined track record of acquisitions allows it to broaden its service offering and geographic footprint, gaining share in existing and adjacent markets.

⚠ Risk Factors to Monitor

Investors should be mindful of several risks inherent to AMN’s business:
  • Macroeconomic and Healthcare Spending: Economic slowdowns or reductions in hospital budgets can constrain spending on temporary staff.
  • Labor Market Cyclicality: Periods of low unemployment and competitive labor conditions may pressure margins as AMN competes for scarce talent or is forced to raise pay rates.
  • Regulatory and Reimbursement Risk: Changes in healthcare policy, labor laws (such as restrictions on temporary staffing), or reimbursement models could affect demand dynamics or operational flexibility.
  • Client Concentration: Large customers, particularly major health systems, sometimes account for a significant portion of revenue, potentially leading to pricing pressure or contract renegotiation risks.
  • Technological Disruption: Increased competition from tech-enabled staffing platforms or direct-hire marketplaces could encroach on traditional staffing models.

📊 Valuation & Market View

AMN Healthcare is typically valued as a hybrid growth-cyclical company, reflecting both the defensive characteristics of healthcare end markets and the cyclicality of staffing demand. Traditional valuation benchmarks include EV/EBITDA and P/E multiples relative to peers in healthcare outsourcing and professional staffing. The company’s ability to generate attractive margins and free cash flows underpins its valuation premium relative to smaller, less diversified staffing companies. Valuation is also supported by its track record of integrating acquisitions and expanding higher-margin technology-enabled services. Market perception often hinges on the trajectory of healthcare labor shortages, the mix shift toward recurring workforce solutions revenue, and AMN’s ability to defend margins against competitive and inflationary wage pressures.

🔍 Investment Takeaway

AMN Healthcare represents a leading platform in the U.S. healthcare staffing sector, with entrenched relationships, broad service capabilities, and growing technology integration. The company is well-positioned to benefit from secular demographic trends and ongoing clinical labor shortages, while its scale and service breadth provide differentiation in a fragmented market. Notwithstanding cyclical and regulatory risks, AMN’s diversified revenue streams and strong execution track record support the case for long-term value creation. The stock offers exposure to an essential, mission-critical healthcare service, with opportunities for organic and acquisitive growth in both traditional and technology-driven workforce solutions.

⚠ AI-generated — informational only. Validate using filings before investing.

Fundamentals Overview

Loading fundamentals overview...

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2025-12-31

"AMN reported revenue of $748.23M for the latest period, with a net income loss of $7.70M and an EPS of -$0.20. The company has total assets of $2.09B and total liabilities of $1.45B, resulting in total equity of $642.11M. Despite a positive operating cash flow of $75.57M and a free cash flow equivalent to operating cash flow, profitability concerns arise as reflected by the negative net income. The balance sheet indicates a net debt of $769.23M, suggesting a higher leverage ratio. With a market price of $18.49, AMN's stock has seen a 1-year decline of approximately 24.5%, juxtaposed with a year-to-date increase of 22.29%. The lack of dividends since 2011 indicates a focus on reinvestment rather than cash returns to shareholders. The price target consensus is set at $22.88, providing a modest upside potential based on market performance. Overall, while revenue generation appears solid, profitability and returns to shareholders are areas of concern that may affect investor confidence."

Revenue Growth

Neutral

Revenue of $748.23M indicates a healthy operation, but growth metrics are not provided.

Profitability

Neutral

Net income is negative, highlighting ongoing profitability challenges.

Cash Flow Quality

Positive

Positive operating cash flow and free cash flow are encouraging, but lack of capital expenditure is noted.

Leverage & Balance Sheet

Caution

High net debt relative to equity poses some risk, despite adequate asset coverage.

Shareholder Returns

Neutral

No dividends paid since 2011 and a substantial drop in price over the past year is concerning.

Analyst Sentiment & Valuation

Fair

Moderate upside based on price targets suggests some analyst optimism despite recent underperformance.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

AMN’s Q4 2025 results were strong on the top line but structurally weak on margins. Revenue beat guidance ($748M, $18M above high end) largely because labor disruption revenue ran $24M above guidance (Q4 labor disruption $124M, nearly doubled YoY). However, margin pressure was material: consolidated gross margin fell 370 bps YoY and 300 bps sequentially, with labor disruption accounting for a 130 bps gross margin drag in Q4; adjusted EBITDA margin fell 290 bps YoY to 7.3%. For Q1 2026, management is baking in ~$600M of additional strike revenue and explicitly guiding for ~300 bps gross margin drag from labor disruption plus ~$40M of incremental SG&A costs. In the Q&A, management emphasized operational containment—dedicated strike teams, playbooks, and tech-enabled onboarding—claiming no meaningful core crowd-out per guidance. Separately, language services “AI disruption” concerns were dismissed; pricing pressure was attributed to competitor consolidation and immigration policy tightening, with mitigation via a tiered service model trial and AI enablement focused on nonclinical workflow where humans aren’t mandated.

AI IconGrowth Catalysts

  • Labor disruption support driving outsized demand (2 large events in Q1; $600M assumed for Q1)
  • Nurse & Allied revenue up 8% YoY and “at high end of guidance” driven by higher-than-anticipated labor disruption revenue
  • Technology: Language Services tiered service strategy trial with several clients; expects gross margin benefits in 2H 2026
  • VMS ShiftWise Flex rollout (early 2025) enabling advanced analytics/reporting + generative/Agentic AI; expectation of moderation in decline (Q1 driver: 2 fewer days)
  • International nurse staffing returning to sequential growth (management narrative)

Business Development

  • New Language Services client wins in Q1 and growing sales pipeline (for later 2026 Language Services YoY growth)
  • Kaiser partnership: strong, long-standing partnership; Kaiser contract through end of 2026 with expectation of an RFP process this year
  • International growth supported by improved visa bulletin dates (Philippines +2 months to Aug 1, 2023; rest-of-world +4 months to Oct 1, 2023)

AI IconFinancial Highlights

  • Q4 consolidated revenue: $748M (2% YoY; 18% sequential) and $18M above high end of guidance; driven by labor disruption revenue $24M above guidance
  • Q4 gross margin: 26.1% (slightly above high end of guidance); down 370 bps YoY and down 300 bps sequentially
  • Labor disruption reduced Q4 consolidated gross margin by 130 bps
  • Q4 adjusted EBITDA: $54M (down 27% YoY; down 5% sequential) and adjusted EBITDA margin 7.3% (down 290 bps YoY; down 180 bps sequential)
  • Q4 EPS: GAAP loss per share ($0.20); adjusted EPS $0.22 (vs $0.75 prior year; $0.39 prior quarter)
  • Q4 net loss: $8M (vs $188M prior year including noncash goodwill impairment; vs $29M net income prior quarter)
  • Q4 Nurse & Allied gross margin: 21.6% (down 220 bps YoY; down 250 bps sequentially due to lower labor disruption margin)
  • Q4 Physician & Leadership revenue: $170M (down 2% YoY; down 5% sequential); locums $136M (flat YoY; down 7% sequential); interim leadership $24M (down 8% YoY; up 4% sequential); search $9M (down 8% YoY; up 1% sequential)
  • Q4 Technology & Workforce: $88M revenue (down 18% YoY; down 14% excluding Smart Square); Language Services revenue $70M (down 9% YoY; down 7% sequential); VMS $16M (down 28% YoY; down 4% sequential)
  • Q4 segment gross margin (Technology & Workforce): 48.1% (down 920 bps YoY; sequential down 340 bps driven by adverse revenue mix shift, lower-margin Language Services, and sale of Smart Square)
  • First quarter 2026 guidance: consolidated revenue $1.225B–$1.24B including ~$600M labor disruption revenue (final amount subject to completion)
  • Q1 guidance gross margin: 23.5%–24.0%; labor disruption revenue reduces consolidated gross margin by ~300 bps
  • Q1 guidance SG&A: ~14.5%–15% of revenue; includes ~$40M additional costs to support labor disruption activity
  • Q1 guidance adjusted EBITDA margin: 9.7%–10.2%; operating margin 5.9%–6.5%
  • Q1 “strike-excluded” math (Trevor Romeo question): stripping out $600M revenue implies $625M–$640M revenue; stripping implied labor disruption gross margin drag implies ~26.8% to ~27% gross margin; underlying adjusted SG&A run rate ~130–135 (for adjusted EBITDA inference)

AI IconCapital Funding

  • Cash & equivalents (12/31): $34M
  • Total debt (12/31): $775M
  • Net leverage ratio (12/31): 3.3x
  • Full-year debt reduction: down $285M in 2025
  • Operating cash flow (Q4): $76M; operating cash flow (FY): $269M
  • Capital expenditures: $8M (Q4); $36M (FY)

AI IconStrategy & Ops

  • Labor disruption operating model: dedicated strike team (sales in leadership + operations roles), trained resources pulled from across company and external sources, and a playbook/procedures to minimize disruption to core business
  • Automation/tech-enabled readiness: event management system built over past 2 years used for strike events; emphasis on seamless onboarding of suppliers during demand spikes
  • Language Services: “tiered service strategy” to address price competition already in trial with several clients; expects gross margin benefits in 2H 2026; expanding AI enablement for nonclinical/admin interactions while maintaining human interpreters for regulated clinical settings
  • VMS: focus after ShiftWise Flex rollout on enhanced capabilities (advanced analytics/reporting, generative/Agentic AI, expanded support for float pool/agency management)

AI IconMarket Outlook

  • Q1 2026 Nurse & Allied: management expects Nurse & Allied revenue to be up >135% YoY (or excluding labor disruption, up 2% to 4% YoY; and up 4% to 6% from Q4)
  • Q1 2026 Physician & Leadership: revenue down 5% to 8% YoY (interim down mid-single digits; search flat to up; locums down mid-single digits due to disruption in early-year demand from strike events and seasonal declines); sequential growth expected in middle quarters
  • Q1 2026 Technology & Workforce: revenue down mid- to upper teens YoY (low teens excluding Smart Square); Language Services modestly lower sequentially; VMS decline moderating driven by 2 fewer days
  • Visa bulletin update implies management expects mid-teens growth in international in 2026 (higher-margin business)

AI IconRisks & Headwinds

  • Labor disruption creates margin drag: labor disruption revenue reduces consolidated gross margin by ~300 bps in Q1 (and 130 bps in Q4)
  • Potential allocation/crowding risk acknowledged but management claims no meaningful impact on core staffing demand; however, they note marginal impact on some core business from corporate resource reallocation during large events
  • Language Services pricing pressure driven by an aggressive competitor consolidator and tougher immigration policies (explicitly stated as not AI-related)
  • AI disruption fears: management asserts the regulated clinical language services model requires human interpreters and has no observed client demand to replace clinical interpretation with AI
  • VMS revenue headwind continues (Q4 down 28% YoY; Q1 decline expected to continue, though moderation due to fewer days)
  • Physician/Leadership: locums down mid-single digits in Q1 YoY due to early-year demand disruption tied to strike events and seasonal declines
  • Geographic labor concentration: strike events concentrated in 2 places; California licensing constraint limits eligible supply

Sentiment: MIXED

Note: This summary was synthesized by AI from the AMN Q4 2025 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
📁

SEC Filings (AMN)

© 2026 Stock Market Info — AMN Healthcare Services, Inc. (AMN) Financial Profile